Literature DB >> 2125695

Antiproliferative activity of L-asparaginase of Tetrahymena pyriformis on human breast cancer cell lines.

D A Kyriakidis1, S A Tsirka, I K Tsavdaridis, S N Iliadis, A H Kortsaris.   

Abstract

Purified L-asparaginase of Tetrahymena pyriformis is a multi-subunit enzyme exhibiting protein kinase activity as well. The enzyme's L-asparaginase activity is affected by its phosphorylation state. Both native and dephosphorylated L-asparaginase show antiproliferative activity on three breast cancer cell lines (T47D, BT20 and MCF-7) and on Walker 256 cells. These cells do not possess measurable L-asparaginase or L-asparagine synthetase activity. When T47D cells are treated for different times with L-asparaginase and then placed in fresh medium, the growth of cells treated for 1, 3, or 6 hours is initiated and parallels control curve, while the growth of cells treated for 24 or 48 hours with L-asparaginase stays at the same inhibitory level (24 h treatment) or continues to drop (48 h treatment). Addition of D-asparagine, a competitive inhibitor of T. pyriformis L-asparaginase, counteracts the antiproliferative activity of L-asparaginase, indicating that L-asparaginase and not the kinase activity is responsible for that effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125695     DOI: 10.1007/bf00420905

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

Review 1.  L-asparaginase: a review.

Authors:  J C Wriston; T O Yellin
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1973

Review 2.  Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.

Authors:  R H Adamson; S Fabro
Journal:  Cancer Chemother Rep       Date:  1968-10

Review 3.  The inhibition of lymphocyte mitogenesis by asparaginase: a still unexplained phenomenon.

Authors:  D Kafkewitz; A Bendich
Journal:  Experientia       Date:  1984-11-15

4.  Mitochondrial protein synthesis is inhibited by 2'-5' linked oligoadenylic acid triphosphate.

Authors:  A Kortsaris; T Karemfillis; S I Koliais; J Taylor-Papadimitriou
Journal:  Biochem Biophys Res Commun       Date:  1980-10-31       Impact factor: 3.575

5.  Glutaminase-free asparaginase from vibrio succinogenes: an antilymphoma enzyme lacking hepatotoxicity.

Authors:  J A Distasio; A M Salazar; M Nadji; D L Durden
Journal:  Int J Cancer       Date:  1982-09-15       Impact factor: 7.396

6.  L-asparaginase entrapped in liposomes: preparation and properties.

Authors:  Y Fishman; N Citri
Journal:  FEBS Lett       Date:  1975-12-01       Impact factor: 4.124

7.  A model for the regulation of the activity of L-asparaginase/ kinase enzyme of Tetrahymena pyriformis.

Authors:  S A Tsirka; D A Kyriakidis
Journal:  Biochem Int       Date:  1989-07

8.  A comparative study on the effectiveness of various procedures for attachment of two proteins (L-asparaginase and horse radish peroxidase) to the surface of liposomes.

Authors:  E Claassen; N van Rooijen
Journal:  Prep Biochem       Date:  1983

9.  In vitro alterations of L-asparaginase activity of Tetrahymena pyriformis by lipids.

Authors:  S A Tsirka; D A Kyriakidis
Journal:  Mol Cell Biochem       Date:  1988-10       Impact factor: 3.396

10.  Ornithine decarboxylase and phosphatase activity can be stimulated by low concentrations of interferon in human breast cancer cell lines.

Authors:  A Kortsaris; D A Kyriakidis
Journal:  Microbiologica       Date:  1988-10
View more
  2 in total

1.  L-asparaginase of Thermus thermophilus: purification, properties and identification of essential amino acids for its catalytic activity.

Authors:  A A Pritsa; D A Kyriakidis
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

2.  A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.

Authors:  Maristella Maggi; Steven D Mittelman; Jean Hugues Parmentier; Giorgio Colombo; Massimiliano Meli; Jeannette Marie Whitmire; D Scott Merrell; Julian Whitelegge; Claudia Scotti
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.